L Béïque

1.2k total citations · 1 hit paper
13 papers, 811 citations indexed

About

L Béïque is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, L Béïque has authored 13 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Epidemiology. Recurrent topics in L Béïque's work include HIV/AIDS drug development and treatment (7 papers), Hepatitis C virus research (3 papers) and HIV/AIDS Research and Interventions (2 papers). L Béïque is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), Hepatitis C virus research (3 papers) and HIV/AIDS Research and Interventions (2 papers). L Béïque collaborates with scholars based in Canada and United States. L Béïque's co-authors include Thomas R. Einarson, David Chitayat, Laura Park‐Wyllie, Irena Nulman, Anne Pastuszak, Sheila Jacobson, Mark Friesen, Paolo Mazzotta, Myla E. Moretti and Orna Diav‐Citrin and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Clinical Pharmacology & Therapeutics and Annals of Pharmacotherapy.

In The Last Decade

L Béïque

13 papers receiving 774 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies

2000 624 citations Laura Park‐Wyllie, Paolo Mazzotta et al. Teratology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L Béïque Canada	8	457	259	185	112	112	13	811
Nicole M. Sifontis United States	8	343 0.8×	151 0.6×	67 0.4×	94 0.8×	92 0.8×	19	573
Giselle Guerra United States	24	335 0.7×	94 0.4×	631 3.4×	106 0.9×	311 2.8×	90	1.9k
Seema Chopra India	17	306 0.7×	70 0.3×	229 1.2×	205 1.8×	125 1.1×	80	926
Andrea R. Spence Canada	21	213 0.5×	92 0.4×	245 1.3×	210 1.9×	399 3.6×	67	1.1k
Paul Warwicker United Kingdom	17	269 0.6×	667 2.6×	109 0.6×	187 1.7×	175 1.6×	33	1.6k
Cüneyt Eftal Taner Türkiye	20	316 0.7×	67 0.3×	102 0.6×	303 2.7×	202 1.8×	83	1.1k
María José Pérez‐Sáez Spain	20	284 0.6×	249 1.0×	485 2.6×	38 0.3×	177 1.6×	110	1.4k
Sandeep Guleria India	17	637 1.4×	80 0.3×	659 3.6×	129 1.2×	167 1.5×	99	1.6k
Kala Vasishta India	18	286 0.6×	100 0.4×	378 2.0×	243 2.2×	184 1.6×	44	980
Irmeli Nupponen Finland	15	248 0.5×	137 0.5×	225 1.2×	217 1.9×	317 2.8×	35	954

Countries citing papers authored by L Béïque

Since Specialization

Citations

This map shows the geographic impact of L Béïque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Béïque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Béïque more than expected).

Fields of papers citing papers by L Béïque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Béïque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Béïque. The network helps show where L Béïque may publish in the future.

Co-authorship network of co-authors of L Béïque

This figure shows the co-authorship network connecting the top 25 collaborators of L Béïque. A scholar is included among the top collaborators of L Béïque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Béïque. L Béïque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Béïque, L, et al.. (2019). Duration of Antibiotic Therapy in Sepsis Secondary to Urinary Stones: A Retrospective Observational Study. The Canadian Journal of Hospital Pharmacy. 72(4). 331–333. 2 indexed citations

2.

Leung, Valerie, Michael Li, Bradley J. Langford, et al.. (2018). Evaluating Antimicrobial Use and Spectrum of Activity in Ontario Hospitals: Feasibility of a Multicentered Point Prevalence Study. Open Forum Infectious Diseases. 5(6). ofy110–ofy110. 11 indexed citations

3.

Béïque, L & Rosemary Zvonar. (2015). Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients. The Canadian Journal of Hospital Pharmacy. 68(4). 318–26. 28 indexed citations

4.

Porte, C. J. L. la, John P. Sabo, L Béïque, & D. William Cameron. (2009). Lack of Effect of Efavirenz on the Pharmacokinetics of Tipranavir-Ritonavir in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 53(11). 4840–4844. 1 indexed citations

5.

Béïque, L, Pierre Giguère, Charles la Porte, & Jonathan B. Angel. (2007). Interactions between protease inhibitors and acid‐reducing agents: a systematic review. HIV Medicine. 8(6). 335–345. 22 indexed citations

6.

Porte, C. J. L. la, L Béïque, Brian C. Foster, et al.. (2007). The Effect of ABCB1 Polymorphism on the Pharmacokinetics of Saquinavir Alone and in Combination with Ritonavir. Clinical Pharmacology & Therapeutics. 82(4). 389–395. 13 indexed citations

7.

Balfour, Louise, John Kowal, Giorgio A. Tasca, et al.. (2007). Development and psychometric validation of the HIV Treatment Knowledge Scale. AIDS Care. 19(9). 1141–1148. 46 indexed citations

8.

Sheehan, Nancy L., et al.. (2003). Evaluation of HIV Drug Interaction Web Sites. Annals of Pharmacotherapy. 37(11). 1577–1586. 18 indexed citations

9.

Kelly, Deborah, et al.. (2002). Extrapyramidal Symptoms with Ritonavir/Indinavir Plus Risperidone. Annals of Pharmacotherapy. 36(5). 827–830. 37 indexed citations

10.

Kelly, Deborah, L Béïque, & M Ian Bowmer. (2002). Extrapyramidal Symptoms with Ritonavir/Indinavir plus Risperidone. Annals of Pharmacotherapy. 36. 827–830. 4 indexed citations

11.

Park‐Wyllie, Laura, Paolo Mazzotta, Anne Pastuszak, et al.. (2000). Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta-analysis of epidemiological studies. Teratology. 62(6). 385–392. 624 indexed citations breakdown →

12.

Mazzotta, Paolo, Anne Pastuszak, Myla E. Moretti, et al.. (2000). Birth defects after maternal exposure to corticosteroids: Prospective cohort study and meta‐analysis of epidemiological studies. Teratology. 62(6). 385–392. 4 indexed citations

13.

Béïque, L, et al.. (1998). Are the new selective alpha-blockers better than non-selective alpha-blockers for benign prostatic hyperplasia?. PubMed. 44. 2659–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact